コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 and vaccinia virus (previous DryVax smallpox vaccination).
2 disappeared within 2 months after the final vaccination.
3 in the bone marrow for several months after vaccination.
4 for generating high-avidity T cells through vaccination.
5 8 participants in the group after the second vaccination.
6 derlying differential responses to influenza vaccination.
7 5 new SCCs and 0.92 new BCCs per year before vaccination.
8 urs, and strengthening community support for vaccination.
9 or in any organ 1 month following the 14(th) vaccination.
10 mary CD4(+) T cell response during NS4B-P38G vaccination.
11 secrete protective antibodies within days of vaccination.
12 to nonvaccinia OPXV infections from smallpox vaccination.
13 e used as an immunostimulant for microneedle vaccination.
14 ccine candidates in mice and compared to DNA vaccination.
15 hlighted by WHO to inform potential maternal vaccination.
16 tection and risk associated with RTS,S/AS01E vaccination.
17 by descendants of NVT clones present before vaccination.
18 e T cells of high functional avidity through vaccination.
19 all adverse events in the 28 days after each vaccination.
20 2 new SCCs and 2.25 new BCCs per year before vaccination.
21 ady higher than those of young adults before vaccination.
22 siRNA, to treat localised disease or provide vaccination.
23 anding repertoire responses to infection and vaccination.
24 sponse to diphtheria toxoid and pneumococcal vaccination.
25 HCDR3-binder bnAbs via sequential HIV-1 Env vaccination.
26 cells that may affect immune responses upon vaccination.
27 tly higher than 2 weeks after the last RV144 vaccination.
28 ut these can be easily perturbed, such as by vaccination.
29 exual males in settings with female-only HPV vaccination.
30 hese, 22% were in the group age-eligible for vaccination.
31 n broaden humoral responses following rabies vaccination.
32 tential to tailor the immune response to DNA vaccination.
33 on of sterile immunity during whole-organism vaccination.
34 c symmetry has ushered in a new era in HIV-1 vaccination.
35 ples from a country with universal rotavirus vaccination.
36 ving personal belief exemptions of childhood vaccination.
37 missed opportunities to initiate hepatitis B vaccination.
38 dosing schemes have driven down the cost of vaccination.
39 ctions has been a long-sought-after goal for vaccination.
40 nses at early time points after infection or vaccination.
41 lation-level impact in males from female HPV vaccination.
42 1 + 1 schedule) delivered with other routine vaccinations.
43 inate P falciparum before the first and last vaccinations.
44 ll children had a history of prior influenza vaccinations.
45 uded only participants who received all five vaccinations.
48 nic adjuvant formulation 09, render low-dose vaccination a feasible and promising approach for genera
49 tion at GTEN sites, 16% met criteria for MMR vaccination according to the provider's assessment, but
52 vider registeries) reporting on yellow fever vaccination activities between May 1, 1939, and Oct 29,
53 ratio, 1.04; 95% CI, 0.68-1.58) or influenza vaccination (adjusted hazard ratio, 1.10; 95% CI, 1.00-1
54 identified individual data on herpes zoster vaccinations administered and consultations for herpes z
55 tionwide registers, we linked information on vaccination, adverse pregnancy outcomes, and potential c
56 Our results demonstrate that incremental vaccination against a single chemical species within a m
59 ation of America (MGFA) class II-IV disease, vaccination against Neisseria meningitides, and previous
60 ch-up (AGW = 9.9, CC = 678) and routine-only vaccination (AGW = 9.9, CC = 677), thus providing simila
61 herd immunity above that achieved by direct vaccination alone but also increases the opportunity for
63 s of the areas that could be prioritised for vaccination, although other constraints such as vaccine
64 ociation between influenza VE and time since vaccination among patients >/=9 years old with medically
65 emic reactogenicity in the 7 days after each vaccination and all adverse events in the 28 days after
67 ation between bacillus Calmette-Guerin (BCG) vaccination and childhood asthma in a birth cohort using
68 ributed in part to the cessation of smallpox vaccination and concomitant waning of population-level i
70 te the introduction of universal hepatitis B vaccination and effective antiviral therapy, the estimat
72 s in the vaccine group 1 day after the first vaccination and in and two (2%) of 98 participants in th
74 d macaque cross-reactive V3 NAbs elicited by vaccination and prototypic V3 NAbs derived from natural
75 ngland in view of differences and changes in vaccination and screening uptake by ethnicity in England
78 participants who received at least one trial vaccination) and the immunogenicity analyses were based
80 ion, accelerated tissue formation, effective vaccination, and nanotherapeutics for targeted disease t
81 group subpopulations can be prioritized for vaccination, and the vaccine interventions are cost savi
82 verse events occurred in the first day after vaccination, and were mild to moderate in intensity, of
83 d adaptive anti-PDAC immunity when used in a vaccination approach, direct tumor injection or intraven
84 ter understand the response to infection and vaccination, as well as the dysregulation that occurs in
86 RC 320 participants were assigned to receive vaccinations at 0, 4, and 8 weeks via single-dose needle
87 orphology can be detected for 10 years after vaccination/BrdU administration, indicating that plasma
88 sed initially on generating demand for polio vaccination but later expanded its messaging to promote
89 n against infections can be achieved through vaccination, but the optimal vaccination schedule in lun
90 high for the three IPV-Al vaccines after two vaccinations, but was higher after three vaccinations (i
91 s study suggest that efficacy of oral rabies vaccination by aerial delivery is associated with landsc
93 letion of enrolment, we implemented an mOPV2 vaccination campaign that targeted 40% of children young
94 e risk of Sabin 2 transmission after a polio vaccination campaign with a monovalent type 2 oral polio
95 ake recommendations to help improve reactive vaccination campaigns against cholera, and discuss the i
100 disease, vaccination is recommended; whether vaccination can protect by opsonophagocytic activity in
101 radius was found to be highly dependent upon vaccination capacity for all management objectives.
104 ibition (HAI) titers, more than 8-month post-vaccination compared to influenza VLPs without CCL28 or
105 tly higher at day 28 after microneedle patch vaccination compared with placebo (all p<0.0001) and wer
106 Similarly, the increasing trend in child vaccination completion during the pre-epidemic period wa
110 sources, including personnel, for increasing vaccination coverage and improved performance monitoring
111 ntion were used to simulate county-level MMR vaccination coverage in children (age 2-11 years) in the
114 stem utilization with influenza illness, and vaccination coverage through active community-based surv
116 population density, forest cover and routine vaccination coverage were the strongest predictors of po
118 to consider possible explanations including vaccination coverage, changes in screening for cervical
122 accine have supported that influenza A(H1N1) vaccination does not increase the risk for major pregnan
124 Some women will have inadvertent exposure to vaccination during early pregnancy, but few data exist r
132 risons revealed substantial increases in HPV vaccination during this time period, and more modest red
133 years) after high-risk groups for influenza vaccination during times of limited vaccine supplies.
136 l polio vaccine (OPV) has enabled world-wide vaccination efforts, which resulted in nearly complete c
141 On Sept 1, 2008, Scotland launched routine vaccination for human papillomavirus (HPV) types 16 and
142 erent RSV immunisation strategies (targeting vaccination for infants, or pregnant women, or prophylac
143 ved decreasing VE with increasing time since vaccination for influenza A(H3N2) (p=0.004), influenza A
144 ditional boosts, given 6-8 years since RV144 vaccination, for safety and immunogenicity, at weeks 0 a
145 or without ALVAC-HIV 6-8 years after initial vaccination generated higher humoral responses than afte
149 Those animals that received only vaginal vaccinations had identical IgG but superior IgA response
150 -40) who have a combination of screening and vaccination history, and weighted to estimate the popula
151 two vaccinations, but was higher after three vaccinations (ie, after completion of the expanded progr
152 model, absence of gammadelta T cells during vaccination impaired protective CD8 T cell responses and
153 an antibodies following natural infection or vaccination.IMPORTANCE The four serotypes of dengue viru
154 V13 before and at 1, 12, and 24 months after vaccination in 1006 PCV13 recipients and 1005 controls w
156 ong vaccinated individuals from day 10 after vaccination in both randomised and non-randomised cluste
158 study suggests that the introduction of HPV vaccination in England will initially widen a pre-existi
159 tween the cross-reactive V3 NAbs elicited by vaccination in macaques and natural infections in humans
162 children whose mothers received an influenza vaccination in their first trimester, but the associatio
165 iminished innate immune responses, vDeltaK1L vaccination induced a protective VACV-specific CD8(+) T
167 ay differentially affect cross-reactivity of vaccination-induced H3-specific hemagglutination inhibit
171 old increased risk of meningococcal disease, vaccination is recommended; whether vaccination can prot
172 er strategy 5 weeks after standard influenza vaccination is safe and effective and induces an increas
175 asing due to the absence of routine smallpox vaccination leading to a higher proportion of naive popu
176 ention of infections, adherence with routine vaccinations, management of comorbid conditions, and adh
180 ing treated with eculizumab and suggest that vaccination may provide better protection against mening
181 uggested that Bacillus Calmette-Guerin (BCG) vaccination may reduce the risk of allergic diseases, in
191 in 47 clusters randomly assigned to delayed vaccination (of whom 3096 were eligible, 2539 consented,
192 n 51 clusters randomly assigned to immediate vaccination (of whom 3232 were eligible, 2151 consented,
194 of the study, none of which were related to vaccination (one in the Vi-TT group and three in the Vi-
195 accine, we demonstrate the advantage of skin vaccination over intramuscular delivery of a two-fold hi
197 After intradermal, but not intramuscular, vaccination, participants with AD with S aureus coloniza
198 SVDeltaG pseudovirions serve as a successful vaccination platform in a rodent model of Ebola virus di
202 usceptibility in response to demographic and vaccination processes emphasizes the importance of progr
204 per 100,000 (IQR, 260-370), while postnatal vaccination produced a minimal reduction, with an incide
205 bination mass drug administration and a mass vaccination program approach to eliminate malaria from g
206 V types and non-4vHPV types suggest that the vaccination program has had an impact on the prevalence
208 this end, the country enhanced its mandatory vaccination programs and achieved vaccination rates repo
212 PEM is endemic may be one strategy to boost vaccination-promoted immunity and improve outcomes assoc
214 nd potentially transformative strategies for vaccination, protein replacement therapy, and genome edi
223 tainty exists as to whether low-risk elderly vaccination remains cost-effective, driven by the choice
227 second- rather than third-trimester maternal vaccination results in higher birth anti-pertussis toxin
229 chieved through vaccination, but the optimal vaccination schedule in lung transplant recipients is un
232 ile few participants completed the full MenB vaccination series, limiting analytic power, these data
233 hain in 23 health facilities and 36 outreach vaccination sessions in 8 districts and cities of Bangla
234 nized with S aureus, intramuscular influenza vaccination should be given preference in these patients
235 igher functional avidity induced by low-dose vaccinations showed higher cytokine release per cell and
237 ing that widespread use of childhood measles vaccination since 1963 resulted in a decrease in average
238 irmed influenza infection as the outcome and vaccination status defined by days between vaccination a
242 ctiveness of alternative maternally targeted vaccination strategies (antenatal delivery vs. postnatal
243 viously used in the United Kingdom to inform vaccination strategies for influenza, with extensions to
246 tant implications for the design of maternal vaccination strategies that could synergize with ART dur
252 INTERPRETATION: The results show that a ring vaccination strategy can be rapidly and safely implement
253 ous prime-boost may provide a more effective vaccination strategy to broaden the antibody responses t
255 ntially the design of attenuated viruses for vaccination studies.IMPORTANCE SFTS phlebovirus (SFTSV)
256 an loss does not influence immunogenicity or vaccination success.IMPORTANCE The West African Ebola vi
257 nt reduction in HPV prevalence 4 years after vaccination suggests that the bivalent HPV-16/18 vaccine
259 rritation, in marked contrast to intradermal vaccination that provoked severe inflammation and bruise
262 cells following influenza virus infection or vaccination, they failed to support activation of naive
264 ere collected before the influenza season or vaccination to assess antibody and T-cell responses.
265 th impact and cost-effectiveness of offering vaccination to MSM who visit genitourinary medicine (GUM
267 e did an open-label, cluster-randomised ring vaccination trial (Ebola ca Suffit!) in the communities
268 It highlights the shortcomings of the RV144 vaccination trial [ALVAC-HIV (vCP1521) and AIDSVAX B/E]
271 e findings highlight the efficacy of mucosal vaccination via this attenuated strain and will guide it
272 during a measles epidemic in 2013-2014, MMR vaccination was also offered to 6-14-month-olds in munic
275 specific analyses, first-trimester influenza vaccination was the only period associated with increase
279 ecific CD8(+)CD57(+) senescent T cells after vaccination, which were already higher than those of you
280 boosted group as well, indicating that skin vaccination with 4M2e-tFliC facilitated a long-term anti
282 developing medical countermeasures and that vaccination with a mutant lacking expression of the prot
283 aper on the preventive effect of tolerogenic vaccination with a strong agonist insulin mimetope in ty
286 tion; however, only passive immunization, or vaccination with inactive SpeA, resulted in high-titer S
290 ses elicited by prior infection with DENV or vaccination with tetravalent dengue attenuated vaccines
291 ding prompted us to test the hypothesis that vaccination with the batA mutant strain elicits protecti
292 led that the protective immunity afforded by vaccination with the batA mutant strain is predominantly
293 was reported in Guinea, and in response ring vaccination with the unlicensed rVSV-ZEBOV vaccine was i
294 HV-1-reactive IgG subtypes demonstrated that vaccination with the VC2-EHV-1-gD vaccine stimulated rob
297 en </=33 years had been age-eligible for HPV vaccination, with 3-dose uptake across age cohorts being
298 e fusion protein.IMPORTANCE Due to lapses in vaccination worldwide that have caused localized outbrea
299 There are windows of opportunity in which vaccination would be beneficial, but to date, no vaccine
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。